Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7500 p527
3 May 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Guild’s parent union rejects three-year pay deal for NHS employees

Proposals for a three-year pay deal for NHS staff have been rejected by the union that includes the Guild of Healthcare Pharmacists.

Unite, the guild’s parent union, has rejected the proposal of a cumulative pay increase of nearly 8 per cent over the next three years (PJ, 12 April 2008, p424), saying that it wants further pay talks with the Government and NHS Employers.

Kevin Coyne, head of health at Unite, said: “We cannot be tied to a three-year deal, given the future uncertainties in the economy and the inflationary pressures that our hard-working members are experiencing on a daily basis.” Unite also wants to maintain the independence of the Pay Review Body (PRB) to arbitrate pay on an annual basis.

Unite’s rejection of the pay deal follows a warning from NHS chief executive David Nicholson that ministers could impose a staged pay award this year if unions do not accept the pay package.

Dave Thornton, chairman of the terms and conditions committee of the GHP, emphasised that the guild supports this year’s proposed pay award of 2.75 per cent, which was in line with the PRB’s recommendation, but added: “The three-year proposal has too much risk involved for our members. While the pay offer does have a statement in there to revisit the deal if inflationary pressures are higher than expected, this is not a robust safeguard to protect our members from a potential pay cut in years 2 and 3.”

Dave Miller, vice-president of the guild, said: “Guild council understands the genuine concerns behind the decision and agrees with the conclusion not to support this multi-year deal in a period of economic uncertainty. We also back the need to strengthen and defend the independence of the PRB to arbitrate pay on an annual basis, including consideration of additional premiums to deal with the problems of recruitment and retention due to market forces — ideally without English health ministers intervening to stage the award.”

He added that members will discuss the pay deal with Mr Coyne at the joint GHP/United Kingdom Clinical Pharmacy Association conference next week.

Back to Top


©The Pharmaceutical Journal